Systematic Review of Induced Pluripotent Stem Cell Technology as a Potential Clinical Therapy for Spinal Cord Injury
Transplantation therapies aimed at repairing neurodegenerative and neuropathological conditions of the central nervous system (CNS) have utilized and tested a variety of cell candidates, each with its own unique set of advantages and disadvantages. The use and popularity of each cell type is guided...
Main Authors: | Anne S. Kramer, Alan R. Harvey, Giles W. Plant, Stuart I. Hodgetts |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-04-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368912X655208 |
Similar Items
-
Human Mesenchymal Precursor Cells (Stro-1) from Spinal Cord Injury Patients Improve Functional Recovery and Tissue Sparing in an Acute Spinal Cord Injury Rat Model
by: Stuart I. Hodgetts, et al.
Published: (2013-03-01) -
Induced pluripotent stem cell technology for spinal cord injury: a promising alternative therapy
by: Yu Li, et al.
Published: (2021-01-01) -
Pluripotent Stem Cells for Spinal Cord Injury Repair
by: Maria Martin-Lopez, et al.
Published: (2021-11-01) -
Cell therapy for spinal cord injury using induced pluripotent stem cells
by: Narihito Nagoshi, et al.
Published: (2019-12-01) -
Regenerative Medicine for Spinal Cord Injury Using Induced Pluripotent Stem Cells
by: Narihito Nagoshi, et al.
Published: (2024-01-01)